Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?
Clinical trial NCT03227562 · TERMINATED
Trial details
- NCT number
- NCT03227562
- Sponsor
- Marion Trousselard
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-01
- Primary completion
- 2021-09-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.